Anti-miR-873-5p improves alcohol-related liver disease by enhancing hepatic deacetylation via SIRT1

Harden, 1906, The alcoholic ferment of yeast-juice. Part II.—the coferment of yeast-juice, Proc R Soc Lond B Biol Sci, 78, 369, 10.1098/rspb.1906.0070 Xie, 2020, NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential, Signal Transduct Target Ther, 5, 227, 10.1038/s41392-020-00311-7 Cabezas, 2022, Management of alcohol-related liver disease and its complications, Clin Drug Investig, 42, 47, 10.1007/s40261-022-01143-9 Jiang, 2020, Alcohol metabolizing enzymes, microsomal ethanol oxidizing system, cytochrome P450 2E1, catalase, and aldehyde dehydrogenase in alcohol-associated liver disease, Biomedicines, 8, 50, 10.3390/biomedicines8030050 Lemasters, 2006, Voltage-dependent anion channel (VDAC) as mitochondrial governator - thinking outside the box, Biochim Biophys Acta Mol Basis Dis, 1762, 181, 10.1016/j.bbadis.2005.10.006 Lieber, 1975, Effect of chronic alcohol consumption on ethanol and acetaldehyde metabolism, Adv Exp Med Biol, 59, 185, 10.1007/978-1-4757-0632-1_14 Addolorato, 2016, Treatment of alcohol use disorders in patients with alcoholic liver disease, J Hepatol, 65, 618, 10.1016/j.jhep.2016.04.029 Xu, 2019, MicroRNAs in alcoholic liver disease: recent advances and future applications, J Cell Physiol, 234, 382, 10.1002/jcp.26938 Fernández-Tussy, 2019, miR-873-5p targets mitochondrial GNMT-Complex II interface contributing to non-alcoholic fatty liver disease, Mol Metab, 29, 40, 10.1016/j.molmet.2019.08.008 Idalsoaga, 2020, Non-alcoholic fatty liver disease and alcohol-related liver disease: two intertwined entities, Front Med (Lausanne), 7, 448, 10.3389/fmed.2020.00448 Craciun, 2020, Nonalcoholic fatty liver disease versus alcohol-related liver disease: is it really so different?, Curr Pharm Des, 26, 1093, 10.2174/1381612826666200122152417 Fernández-Ramos, 2018, MiR-873-5p acts as an epigenetic regulator in early stages of liver fibrosis and cirrhosis, Cell Death Dis, 9, 958, 10.1038/s41419-018-1014-y Rodríguez-Agudo, 2022, Methionine cycle rewiring by targeting miR-873-5p modulates ammonia metabolism to protect the liver from acetaminophen, Antioxidants, 11, 897, 10.3390/antiox11050897 Hong, 2018, Nicotinamide N-methyltransferase interacts with enzymes of the methionine cycle and regulates methyl donor metabolism, Biochemistry, 57, 5775, 10.1021/acs.biochem.8b00561 Bertola, 2013, Mouse model of chronic and binge ethanol feeding (the NIAAA model), Nat Protoc, 8, 627, 10.1038/nprot.2013.032 Blaya, 2016, Integrative microRNA profiling in alcoholic hepatitis reveals a role for microRNA-182 in liver injury and inflammation, Gut, 65, 1535, 10.1136/gutjnl-2015-311314 Argemi, 2019, Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis, Nat Commun, 10, 3126, 10.1038/s41467-019-11004-3 Niu, 2022, Noninvasive proteomic biomarkers for alcohol-related liver disease, Nat Med, 28, 1277, 10.1038/s41591-022-01850-y Benedé-Ubieto, 2021, An experimental DUAL model of advanced liver damage, Hepatol Commun, 5, 1051, 10.1002/hep4.1698 Ribeiro, 2004, Hepatocyte apoptosis, expression of death receptors, and activation of NF-κB in the liver of nonalcoholic and alcoholic steatohepatitis patients, Am J Gastroenterol, 99, 1708, 10.1111/j.1572-0241.2004.40009.x Nagy, 2016, Linking pathogenic mechanisms of alcoholic liver disease with clinical phenotypes, Gastroenterology, 150, 1756, 10.1053/j.gastro.2016.02.035 Marí, 2014, Mitochondrial cholesterol accumulation in alcoholic liver disease: role of ASMase and endoplasmic reticulum stress, Redox Biol, 3, 100, 10.1016/j.redox.2014.09.005 Lieber, 1968, Ethanol oxidation by hepatic microsomes: adaptive increase after ethanol feeding, Science, 162, 917, 10.1126/science.162.3856.917 Cederbaum, 2012, Alcohol metabolism, Clin Liver Dis, 16, 667, 10.1016/j.cld.2012.08.002 Shi, 2022, Endoplasmic reticulum-targeted inhibition of CYP2E1 with vitamin E nanoemulsions alleviates hepatocyte oxidative stress and reverses alcoholic liver disease, Biomaterials, 288, 10.1016/j.biomaterials.2022.121720 Khodaee, 2014, Endoplasmic reticulum membrane potassium channel dysfunction in high fat diet induced stress in rat hepatocytes, EXCLI J, 13, 1075 Grynkiewicz, 1985, A new generation of Ca2+ indicators with greatly improved fluorescence properties, J Biol Chem, 260, 3440, 10.1016/S0021-9258(19)83641-4 Lin, 2019, Selective recruitment of different Ca2+-dependent transcription factors by STIM1-Orai1 channel clusters, Nat Commun, 10, 2516, 10.1038/s41467-019-10329-3 Nevzorova, 2020, Animal models for liver disease–a practical approach for translational research, J Hepatol, 73, 423, 10.1016/j.jhep.2020.04.011 Lieber, 1965, Effects of prolonged ethanol intake: production of fatty liver despite adequate diets, J Clin Invest, 44, 1009, 10.1172/JCI105200 Donohue, 2007, Alcohol-induced steatosis in liver cells, World J Gastroenterol, 13, 4974, 10.3748/wjg.v13.i37.4974 Ren, 2020, Emerging roles of SIRT1 in alcoholic liver disease, Int J Biol Sci, 16, 3174, 10.7150/ijbs.49535 Zhao, 2022, Emerging roles of Sirtuins in alleviating alcoholic liver Disease: a comprehensive review, Int Immunopharmacol, 108, 108712, 10.1016/j.intimp.2022.108712 Zee, 2013, Validation of protein acetylation by mass spectrometry, Methods Mol Biol, 1–11, 10.1007/978-1-62703-305-3_1 Manley, 2015, Role of farnesoid X receptor and bile acids in alcoholic liver disease, Acta Pharm Sin B, 5, 158, 10.1016/j.apsb.2014.12.011 Muthiah, 2022, Development of alcohol-associated hepatitis is associated with specific changes in gut-modified bile acids, Hepatol Commun, 6, 1073, 10.1002/hep4.1885 Ciocan, 2018, Bile acid homeostasis and intestinal dysbiosis in alcoholic hepatitis, Aliment Pharmacol Ther, 48, 961, 10.1111/apt.14949 Wu, 2014, Activation of farnesoid X receptor attenuates hepatic injury in a murine model of alcoholic liver disease, Biochem Biophys Res Commun, 443, 68, 10.1016/j.bbrc.2013.11.057 Nowak, 2020, The impact of acute or chronic alcohol intake on the NF-κB signaling pathway in alcohol-related liver disease, Int J Mol Sci, 21, 1, 10.3390/ijms21249407 Kauppinen, 2013, Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders, Cell Signal, 25, 1939, 10.1016/j.cellsig.2013.06.007 Parker, 2020, Nicotinamide adenine dinucleotide metabolome is functionally depressed in patients undergoing liver transplantation for alcohol-related liver disease, Hepatol Commun, 4, 1183, 10.1002/hep4.1530 Sambeat, 2019, Endogenous nicotinamide riboside metabolism protects against diet-induced liver damage, Nat Commun, 10, 4291, 10.1038/s41467-019-12262-x Song, 2020, ER stress-induced upregulation of NNMT contributes to alcohol-related fatty liver development, J Hepatol, 73, 783, 10.1016/j.jhep.2020.04.038 Roberti, 2021, Nicotinamide N-methyltransferase: at the crossroads between cellular metabolism and epigenetic regulation, Mol Metab, 45, 10.1016/j.molmet.2021.101165 Kleiner, 2005, Design and validation of a histological scoring system for nonalcoholic fatty liver disease, Hepatology, 41, 1313, 10.1002/hep.20701 Liang, 2022, Nicotinamide N-methyltransferase and liver diseases, Genes Dis, 10, 1883, 10.1016/j.gendis.2022.03.019 Way, 2022, Key signaling in alcohol-associated liver disease: the role of bile acids, Cells, 11, 1374, 10.3390/cells11081374 Bergheim, 2005, Treatment of alcoholic liver disease, Dig Dis, 23, 275, 10.1159/000090175 Shmulewitz, 2021, The World Health Organization risk drinking levels measure of alcohol consumption: prevalence and health correlates in nationally representative surveys of US adults, 2001-2002 and 2012-2013, Am J Psychiatry, 178, 548, 10.1176/appi.ajp.2020.20050610 Bala, 2016, The pro-inflammatory effects of miR-155 promote liver fibrosis and alcohol-induced steatohepatitis, J Hepatol, 64, 1378, 10.1016/j.jhep.2016.01.035 Hwang, 2017, Nicotinamide is an inhibitor of SIRT1 in vitro, but can be a stimulator in cells, Cell Mol Life Sci, 74, 3347, 10.1007/s00018-017-2527-8 Zhao, 2019, Celastrol protects from cholestatic liver injury through modulation of SIRT1-FXR signaling, Mol Cell Proteomics, 18, 520, 10.1074/mcp.RA118.000817 Yeung, 2004, Modulation of NF-κB-dependent transcription and cell survival by the SIRT1 deacetylase, EMBO J, 23, 2369, 10.1038/sj.emboj.7600244 Yang, 2022, Regulation of SIRT1 and its roles in inflammation, Front Immunol, 13